- Home
- PLX vs HURC Comparison
PLX vs HURC Comparison
Compare PLX & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- HURC
- Stock Information
- Founded
- PLX 1993
- HURC 1968
- Country
- PLX United States
- HURC United States
- Employees
- PLX N/A
- HURC N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- HURC Industrial Machinery/Components
- Sector
- PLX Health Care
- HURC Industrials
- Exchange
- PLX Nasdaq
- HURC Nasdaq
- Market Cap
- PLX 122.6M
- HURC 102.5M
- IPO Year
- PLX 1998
- HURC N/A
- Fundamental
- Price
- PLX $1.40
- HURC $15.58
- Analyst Decision
- PLX Strong Buy
- HURC
- Analyst Count
- PLX 1
- HURC 0
- Target Price
- PLX $15.00
- HURC N/A
- AVG Volume (30 Days)
- PLX 640.7K
- HURC 31.7K
- Earning Date
- PLX 08-13-2025
- HURC 06-06-2025
- Dividend Yield
- PLX N/A
- HURC N/A
- EPS Growth
- PLX N/A
- HURC N/A
- EPS
- PLX 0.05
- HURC N/A
- Revenue
- PLX $59,764,000.00
- HURC $183,634,000.00
- Revenue This Year
- PLX $65.02
- HURC N/A
- Revenue Next Year
- PLX $57.34
- HURC N/A
- P/E Ratio
- PLX $28.96
- HURC N/A
- Revenue Growth
- PLX 0.18
- HURC N/A
- 52 Week Low
- PLX $0.82
- HURC $13.19
- 52 Week High
- PLX $3.10
- HURC $23.76
- Technical
- Relative Strength Index (RSI)
- PLX 30.38
- HURC 58.12
- Support Level
- PLX $1.52
- HURC $14.25
- Resistance Level
- PLX $1.65
- HURC $15.31
- Average True Range (ATR)
- PLX 0.08
- HURC 0.64
- MACD
- PLX 0.02
- HURC 0.15
- Stochastic Oscillator
- PLX 17.19
- HURC 100.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metal working industry through sales, service and distribution network. The company concentrated on designing user-friendly computer control systems that can be operated by both skilled and unskilled machine tool operators. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.